Antiretroviral therapy for children: challenges and opportunities
- 1 March 2007
- journal article
- review article
- Published by Taylor & Francis in Paediatrics and International Child Health
- Vol. 27 (1) , 1-10
- https://doi.org/10.1179/146532807x170448
Abstract
Currently, <10% of all HIV-infected children who need anti-retroviral therapy in sub-Saharan Africa are actually receiving therapy. Many constraints prevent these children from gaining access to appropriate care, including the magnitude of the paediatric epidemic, competing interests of adult care, health system inadequacies, technical challenges and patient-related factors. These issues form the basis of this paper which discusses the practical challenges of extending optimal care to all deserving children. Besides the need for major human, infrastructural, technical and logistic investments to overcome existing constraints, more clinical research is required before treatment guidelines can be refined in resource-constrained settings. In this regard, the paper lists some important research questions that should be addressed.Keywords
This publication has 41 references indexed in Scilit:
- Safety and efficacy of zinc supplementation for children with HIV-1 infection in South Africa: a randomised double-blind placebo-controlled trialThe Lancet, 2005
- Antiretroviral Treatment in Pediatric HIV Infection in the United StatesFrom Clinical Trials to Clinical PracticeJAMA, 2005
- Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trialThe Lancet, 2004
- Highly active antiretroviral therapies among HIV-1-infected children in Abidjan, Côte d'IvoireAIDS, 2004
- Meeting international goals in child survival and HIV/AIDSThe Lancet, 2002
- HIV-1/AIDS and maternal and child health in AfricaThe Lancet, 2002
- Efficacy of highly active antiretroviral therapy in HIV-1 infected childrenThe Lancet Infectious Diseases, 2002
- Reduction in Mortality With Availability of Antiretroviral Therapy for Children With Perinatal HIV-1 InfectionJAMA, 2000
- A randomized trial of vitamin A supplements in relation to mortality among human immunodeficiency virus-infected and uninfected children in TanzaniaThe Pediatric Infectious Disease Journal, 1999
- The effects of vitamin A supplementation on the morbidity of children born to HIV-infected women.American Journal of Public Health, 1995